FDA Approved: TELMISARTAN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Telmisartan submitted by Jubilant Cadista Pharmaceuticals Inc., under the ANDA pathway. The approval may involve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Stroke

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

SUPPL AP for TELMISARTAN (TELMISARTAN)